InvestorsHub Logo
Followers 51
Posts 4564
Boards Moderated 0
Alias Born 12/14/2009

Re: alexander77 post# 94

Monday, 07/27/2020 6:59:16 AM

Monday, July 27, 2020 6:59:16 AM

Post# of 44690
"VIP is the only pulmonary therapeutic to have been granted Fast Track status by the US FDA and to be allowed into both phase 2/3 clinical trials, as well as an expanded use protocol for those who are unable to enter the clinical trial because of excluded comorbidity."